Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
C5AR1 is a G protein-coupled receptor (GPCR) that serves as the primary receptor for the complement component C5a, an anaphylatoxin generated during activation of the complement system. It plays a central role in mediating inflammatory responses and is implicated in various diseases, including chronic inflammatory diseases, cancer, and COVID-19. Antagonizing this pathway is being explored therapeutically for conditions involving excessive inflammation or immune dysregulation.
Antagonism of C5a binding and downstream signaling
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Complement C5a Receptor 1 (C5AR1).